Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis (Q80805406)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 August 2007

Language	Label	Description	Also known as
English	Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis	scientific article published on 17 August 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Pradip Kumar Sarma

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Ramnath Misra

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Amita Aggarwal

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

17 August 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Clinical Rheumatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

289-294

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral status in juvenile rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopenia is common in adult male patients with active juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17703334

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-007-0701-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17703334%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80805406&oldid=1399546122"